These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36777381)

  • 21. Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.
    Jacobs CD; Gao J; Wang X; Clarke JM; Tong B; Ready NE; Suneja G; Kelsey CR; Torok JA
    Clin Lung Cancer; 2020 May; 21(3):238-246. PubMed ID: 31757764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of neoadjuvant pembrolizumab plus chemotherapy with adjuvant pembrolizumab for early-stage non-small cell lung cancer in the United States.
    Tian W; Niu L; Wang Z; Lu R; Xiao G; Deng F; Tanzhu G; Zhou R
    Front Immunol; 2023; 14():1268070. PubMed ID: 37822936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service.
    Armeni P; Borsoi L; Fornaro G; Jommi C; Grossi F; Costa F
    Clin Ther; 2020 May; 42(5):830-847. PubMed ID: 32354495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancer.
    Sher DJ; Parikh RB; Mays-Jackson S; Punglia RS
    Am J Clin Oncol; 2014 Jun; 37(3):215-21. PubMed ID: 23275277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Economic Analysis of SC24 in Canada: A Randomized Study of SBRT Compared With Conventional Palliative RT for Spinal Metastases.
    Kerba M; Lourenco RA; Sahgal A; Cardet RF; Siva S; Ding K; Myrehaug SD; Masucci GL; Brundage M; Parulekar WR
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1061-1068. PubMed ID: 38218455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.
    Reddy D; van Son M; Peters M; Bertoncelli Tanaka M; Dudderidge T; Cullen E; Ho CLT; Hindley RG; Emara A; McCracken S; Orczyk C; Shergill I; Mangar S; Nigam R; Virdi J; Moore CM; Arya M; Shah TT; Winkler M; Emberton M; Falconer A; Belsey J; Ahmed HU
    J Med Econ; 2023; 26(1):1099-1107. PubMed ID: 37656223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of a population-based AAA screening program for men over 65 years old in Iran.
    Daroudi R; Shafe O; Moosavi J; Salimi J; Bayazidi Y; Zafarghandi MR; Maleki M; Moini M; Farshidmehr P; Sadeghipour P
    Cost Eff Resour Alloc; 2021 May; 19(1):29. PubMed ID: 33985531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of nivolumab plus ipilimumab versus platinum-doublet chemotherapy for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United States.
    Berling M; Chaudhary MA; Yuan Y; Varol N; Dale P; Testa E; Klint J; Lee A; Lubinga SJ; Penrod JR
    J Med Econ; 2022; 25(1):703-711. PubMed ID: 35659172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-Effectiveness Analysis of Venetoclax in Combination with Azacitidine Versus Azacitidine Monotherapy in Patients with Acute Myeloid Leukemia Who are Ineligible for Intensive Chemotherapy: From a US Third Party Payer Perspective.
    Pratz KW; Chai X; Xie J; Yin L; Nie X; Montez M; Iantuono E; Downs L; Ma E
    Pharmacoeconomics; 2022 Aug; 40(8):777-790. PubMed ID: 35696071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison Between Stereotactic and Conventional Radiotherapy for Solitary Lung Tumor After Resection of Lung Cancer.
    Takahashi S; Go T; Anada M; Kinoshita T; Nishide T; Yokomise H; Shibata T
    Anticancer Res; 2019 Jun; 39(6):2957-2962. PubMed ID: 31177135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-utility of stereotactic radiation therapy
    Leung HWC; Chan ALF
    Oncotarget; 2017 Sep; 8(43):75568-75576. PubMed ID: 29088891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service.
    Armeni P; Borsoi L; Fornaro G; Jommi C; Colombo N; Costa F
    Clin Ther; 2020 Jul; 42(7):1192-1209.e12. PubMed ID: 32591103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of nonoperative management versus open and laparoscopic surgery for uncomplicated acute appendicitis in Colombia.
    Guevara-Cuellar CA; Rengifo-Mosquera MP; Parody-Rúa E
    Cost Eff Resour Alloc; 2021 Jun; 19(1):34. PubMed ID: 34112179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness analysis of atezolizumab in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen: a United Kingdom health care perspective.
    Jiang Y; Zhao M; Xi J; Li J; Tang W; Zheng X
    Front Public Health; 2023; 11():1282374. PubMed ID: 37841712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country.
    Lourenção M; Simões Correa Galendi J; Galvão HCR; Antoniazzi AP; Grasel RS; Carvalho AL; Mauad EC; de Oliveira JHC; Reis RM; Mandrik O; Palmero EI
    Front Oncol; 2022; 12():951310. PubMed ID: 35898894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?
    Albright RH; Joseph RM; Wukich DK; Armstrong DG; Fleischer AE
    Clin Orthop Relat Res; 2020 Dec; 478(12):2869-2888. PubMed ID: 32694315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness analysis comparing intensity-modulated radiotherapy with conformational radiotherapy (3D-RT) for prostate cancer in the brazilian health system.
    Viani GA; Arruda CV; Oliveira R
    Rev Assoc Med Bras (1992); 2021 Jun; 67(5):724-730. PubMed ID: 34550263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-Effectiveness of Treatment Strategies for Spinal Metastases.
    Kowalchuk RO; Mullikin TC; Kim DK; Morris JM; Ebner DK; Harmsen WS; Merrell KW; Beriwal S; Waddle MR; Kim H
    Pract Radiat Oncol; 2022; 12(3):236-244. PubMed ID: 35045365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.